HPV & head and neck cancer: a descriptive update
暂无分享,去创建一个
Martin Görner | Tahwinder Upile | Waseem Jerjes | Manuel Bernal-Sprekelsen | M. Stanley | H. Sudhoff | M. Bernal-Sprekelsen | M. Görner | W. Jerjes | T. Upile | Jörg Ebmeyer | Margaret A Stanley | Lars Steinsträsser | Peter KC Goon | Holger H Sudhoff | L. Steinsträsser | J. Ebmeyer | P. Goon
[1] A. Russo,et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] A. Egloff,et al. Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer. , 2008, Seminars in oncology.
[3] S. Fedele,et al. The World Cancer Report and the burden of oral cancer. , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[4] V. Gopalakrishna,et al. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. , 1992, The Journal of general virology.
[5] K. Kurvinen,et al. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. , 1994, British Journal of Cancer.
[6] L. Mariani,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. de Freitas,et al. [Alcohol and cancer]. , 1997, Acta medica portuguesa.
[8] Jacques Bernier,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[9] J. Bourhis,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.
[10] P. Boyle,et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. , 1995, European journal of cancer. Part B, Oral oncology.
[11] T. D. Briant. The treatment of cancer of the head and neck. , 1977, The Journal of otolaryngology.
[12] Xiang‐Dong Wang,et al. Alcohol and cancer: genetic and nutritional aspects , 2004, Proceedings of the Nutrition Society.
[13] B. Murphy,et al. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Yu Shyr,et al. Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma , 2006, Clinical Cancer Research.
[15] F. Stubenrauch,et al. Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers , 1994, International journal of cancer.
[16] E. Munck‐Wikland,et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer , 2006, International journal of cancer.
[17] P. Lambert,et al. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells , 1995, Journal of virology.
[18] P. Burns,et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. , 1977, British Journal of Cancer.
[19] J. Jacobs,et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.
[20] T. Gorlia,et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. , 2007, The New England journal of medicine.
[21] B. Hansson,et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.
[22] J. Lindholm,et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer , 2002, International journal of cancer.
[23] H. Dienes,et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas , 2001, Cancer.
[24] R. Biggar,et al. Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.
[25] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[26] R. Ferris,et al. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. , 2007, European journal of cancer.
[27] J. Pignon,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .
[28] D. Rimm,et al. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] F. Bray,et al. Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.
[30] B. Rose,et al. Variable Oncogene Promoter Activity of Human Papillomavirus Type 16 Cervical Cancer Isolates from Australia , 2001, Journal of Clinical Microbiology.
[31] R. Weber,et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.
[32] S. Syrjänen. HPV infections and tonsillar carcinoma , 2004, Journal of Clinical Pathology.
[33] A. Markoe,et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. , 2007, The New England journal of medicine.
[34] Carole Fakhry,et al. Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.
[35] W. Quint,et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck , 2003, International journal of cancer.
[36] J. Lautenberger,et al. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. , 1997, Cancer research.
[37] M. Gillison,et al. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.
[38] A. Bladström,et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden , 2005, Acta oto-laryngologica.
[39] Eva Negri,et al. Risk factors for oral and pharyngeal cancer in young adults. , 2004, Oral oncology.
[40] S. Syrjänen,et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. , 1983, International journal of oral surgery.
[41] K. Hemminki,et al. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[42] Christopher U. Jones,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. , 2006, The New England journal of medicine.
[43] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.
[44] H. Morgenstern,et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[45] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[46] N. Park,et al. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. , 1991, Carcinogenesis.
[47] D. Oda,et al. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. , 1996, Experimental cell research.
[48] Suzanne L Wolden,et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. , 2006, International journal of radiation oncology, biology, physics.
[49] D. Johnston,et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[50] S. Schwartz,et al. Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[51] B. Rose,et al. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia , 2002, International journal of cancer.
[52] P. Fuchs,et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.
[53] B. Schmidt,et al. Tongue and tonsil carcinoma , 2005, Cancer.
[54] M. Prystowsky,et al. Gene expression profiles in HPV‐infected head and neck cancer , 2007, The Journal of pathology.
[55] R H Hruban,et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.
[56] C. Bokemeyer,et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. , 2008, The New England journal of medicine.
[57] Brian O'Sullivan,et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.
[58] H. Hausen,et al. Papillomaviruses in human cancers , 1999, Proceedings of the Association of American Physicians.
[59] G. Snow,et al. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. , 1992, The Journal of general virology.
[60] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[61] E. Blennow,et al. Physical State of HPV16 and Chromosomal Mapping of the Integrated Form in Cervical Carcinomas , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[62] U. Liebert,et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.